Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer

Colitis is a frequently occurred side effect of immune checkpoint inhibitors (ICIs), which are increasingly used in cancer treatment, whereas antibiotics are widely used to treat colitis, their effectiveness in ICI-associated colitis remains controversial. In this study, we firstly assessed the effe...

Full description

Saved in:
Bibliographic Details
Main Authors: Nan Jing, Luoyang Wang, Huiren Zhuang, Chao Ai, Guoqiang Jiang, Zheng Liu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/9202491
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555179487002624
author Nan Jing
Luoyang Wang
Huiren Zhuang
Chao Ai
Guoqiang Jiang
Zheng Liu
author_facet Nan Jing
Luoyang Wang
Huiren Zhuang
Chao Ai
Guoqiang Jiang
Zheng Liu
author_sort Nan Jing
collection DOAJ
description Colitis is a frequently occurred side effect of immune checkpoint inhibitors (ICIs), which are increasingly used in cancer treatment, whereas antibiotics are widely used to treat colitis, their effectiveness in ICI-associated colitis remains controversial. In this study, we firstly assessed the effectiveness of several commonly used antibiotics and antibiotic cocktails in alleviating of dextran sulfate sodium- (DSS-) induced colitis. We observed that two narrow-spectrum antibiotics, neomycin and metronidazole, were more effective in alleviating colitis, as evidenced by the remission of loss of the body weight, enlargement of the spleen, shortening of the colon, secretion of proinflammatory cytokines, and histological score of the colon tissue. Moreover, these two antibiotics resulted in better relief of colitis symptoms in the MC38 tumor-bearing male mice receiving the anti-PD-L1 mAb (αPD-L1) treatment, compared to the females. In the meantime, an enhanced response to αPD-L1 efficiency against mice colon cancer was observed in the male mouse group upon the application of these two antibiotics. In contrast, both neomycin and metronidazole showed destructive effects on the antitumor efficiency of αPD-L1 in female mice, despite relief from colitis. We found that antibiotic treatment attenuated the increased infiltration of granulocytes and myeloid cells in colon tissue induced by DSS in female mice, while reducing the proportion of Th17 cells in male mice. These differences were further associated with the sex-biased differences in the gut microbiota. These findings indicated that sex-dependent alterations in the gut microbiota should be considered when applying antibiotics for the treatment of ICI-associated colitis.
format Article
id doaj-art-47d3e00a9ce64c48871cac67be2c90ff
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-47d3e00a9ce64c48871cac67be2c90ff2025-02-03T05:49:22ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/9202491Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon CancerNan Jing0Luoyang Wang1Huiren Zhuang2Chao Ai3Guoqiang Jiang4Zheng Liu5Department of Chemical EngineeringSchool of Basic MedicineDepartment of Chemical EngineeringBeijing Tsinghua Changgung HospitalDepartment of Chemical EngineeringDepartment of Chemical EngineeringColitis is a frequently occurred side effect of immune checkpoint inhibitors (ICIs), which are increasingly used in cancer treatment, whereas antibiotics are widely used to treat colitis, their effectiveness in ICI-associated colitis remains controversial. In this study, we firstly assessed the effectiveness of several commonly used antibiotics and antibiotic cocktails in alleviating of dextran sulfate sodium- (DSS-) induced colitis. We observed that two narrow-spectrum antibiotics, neomycin and metronidazole, were more effective in alleviating colitis, as evidenced by the remission of loss of the body weight, enlargement of the spleen, shortening of the colon, secretion of proinflammatory cytokines, and histological score of the colon tissue. Moreover, these two antibiotics resulted in better relief of colitis symptoms in the MC38 tumor-bearing male mice receiving the anti-PD-L1 mAb (αPD-L1) treatment, compared to the females. In the meantime, an enhanced response to αPD-L1 efficiency against mice colon cancer was observed in the male mouse group upon the application of these two antibiotics. In contrast, both neomycin and metronidazole showed destructive effects on the antitumor efficiency of αPD-L1 in female mice, despite relief from colitis. We found that antibiotic treatment attenuated the increased infiltration of granulocytes and myeloid cells in colon tissue induced by DSS in female mice, while reducing the proportion of Th17 cells in male mice. These differences were further associated with the sex-biased differences in the gut microbiota. These findings indicated that sex-dependent alterations in the gut microbiota should be considered when applying antibiotics for the treatment of ICI-associated colitis.http://dx.doi.org/10.1155/2022/9202491
spellingShingle Nan Jing
Luoyang Wang
Huiren Zhuang
Chao Ai
Guoqiang Jiang
Zheng Liu
Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer
Journal of Immunology Research
title Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer
title_full Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer
title_fullStr Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer
title_full_unstemmed Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer
title_short Sex-Biased Immune Responses to Antibiotics during Anti-PD-L1 Treatment in Mice with Colon Cancer
title_sort sex biased immune responses to antibiotics during anti pd l1 treatment in mice with colon cancer
url http://dx.doi.org/10.1155/2022/9202491
work_keys_str_mv AT nanjing sexbiasedimmuneresponsestoantibioticsduringantipdl1treatmentinmicewithcoloncancer
AT luoyangwang sexbiasedimmuneresponsestoantibioticsduringantipdl1treatmentinmicewithcoloncancer
AT huirenzhuang sexbiasedimmuneresponsestoantibioticsduringantipdl1treatmentinmicewithcoloncancer
AT chaoai sexbiasedimmuneresponsestoantibioticsduringantipdl1treatmentinmicewithcoloncancer
AT guoqiangjiang sexbiasedimmuneresponsestoantibioticsduringantipdl1treatmentinmicewithcoloncancer
AT zhengliu sexbiasedimmuneresponsestoantibioticsduringantipdl1treatmentinmicewithcoloncancer